Dopamine Hydrochloride Injection, Solution, Concentrate
Product Images NDC 0409-9104

6 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dopamine Hydrochloride (NDC 0409-9104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Dopamine (Dopamine 01)

Structural Formula Dopamine (Dopamine 01)
Chemical structure of Dopamine Hydrochloride, showing the molecular arrangement including a benzene ring with two hydroxyl groups and an ethylamine side chain associated with hydrochloride.*
FDA Label Image

Hospira Logo (Dopamine 02)

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Principal Display Panel (5 mL Vial Label)
Label for DOPamine Hydrochloride Injection USP, 200 mg/5 mL (40 mg/mL) concentrate for intravenous use. The single-dose 5 mL vial label includes caution to dilute before use, stabilizer and buffer information, NDC 0409-5820-11, and distribution by Hospira, Inc.*
FDA Label Image

Principal Display Panel (5 mL Vial Tray)

Principal Display Panel (5 mL Vial Tray)
Packaging label for DOPamine Hydrochloride Injection, USP 200 mg/5 mL (40 mg/mL) intravenous solution concentrate in a 5 mL single-dose fliptop vial. The label includes dosage strength, NDC numbers 0409-5820-01 and 0409-5820-11, cautions to dilute before use, manufacturer Hospira, Inc., and storage instructions. It also has usage and aseptic technique information.*
FDA Label Image

Principal Display Panel (10 mL Vial Label)

Principal Display Panel (10 mL Vial Label)
Label for DOPamine Hydrochloride injection, USP 400 mg/10 mL (40 mg/mL), single-dose 10 mL vial. The label includes dilution caution and intravenous use warning. Distributed by Hospira, Inc. Additional ingredients listed as stabilizers and buffers. The label features the Hospira logo and an NDC code.*
FDA Label Image

Principal Display Panel (10 mL Vial Tray)

Principal Display Panel (10 mL Vial Tray)
Packaging label for DOPamine Hydrochloride Injection, USP 400 mg/10 mL (40 mg/mL), an intravenous injection solution concentrate. The label is for a 10 mL single-dose fliptop vial and includes the caution that the product must be diluted. The labeler is Hospira, Inc. The label contains dosage strength, storage instructions, and lot and expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.